The Rhode Island House of Representatives has approved legislation to regulate the sale and distribution of kratom, a plant-based product with stimulant and opioid-like properties that’s used both recreationally and medicinally. The vote was 40 to 24.
The measure, titled the Rhode Island Kratom Act, was introduced by Representatives Brian Kennedy, John Edwards, and Grace Diaz. The bill would establish licensing requirements for kratom manufacturers, importers, distributors, and retailers. It also creates strict guidelines for product labeling, prohibits sales to individuals under 21, and sets safety standards for ingredients and packaging.
Under the proposed law, any kratom product that contains synthetic additives, exceeds specific alkaloid thresholds, or mimics candy-like appearances appealing to youth would be banned. It also bars any product intended for smoking or vaping and mandates child-resistant packaging.
The legislation imposes a 15% excise tax on wholesale kratom sales, in addition to the state sales tax. Violations could result in license suspension, product seizures, fines, or even criminal charges for repeated or severe offenses. Revenue generated through licensing and penalties would be directed to a newly established Kratom Administration Account to fund enforcement and regulatory oversight.
Importantly, the bill also amends Rhode Island’s Uniform Controlled Substances Act to ensure that kratom’s primary active compounds—mitragynine and 7-hydroxymitragynine—cannot be placed in Schedule I, effectively protecting the product from being banned outright in the future without further legislative action.
Having cleared the House, the bill now heads to the Senate for further consideration. If enacted, the law would take effect on April 1, 2026.
